Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Effect of Curcuma longa L. Extracts on 5-Alpha Reductase II Activity

울금 추출물의 5-Alpha Reductase II 활성 저해 효과

  • Received : 2013.10.02
  • Accepted : 2014.01.22
  • Published : 2014.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

5-Alpha reductase II, which converts testosterone (T) to dihydrotestosterone (DHT), is a crucial enzyme II in benign prostatic hyperplasia. Inhibitory effects of Curcuma longa L. (CL) extracts on 5-alpha reductase II activity were investigated in rat prostate tissue homogenates as well as LNCaP cells expressing human 5-alpha reductase II. Hot water extract (CL-HW) of Curcuma longa L. significantly inhibited 5-alpha reductase activity by over 80% at a concentration of $100{\mu}g/mL$, whereas 20% ethanol extracts (CL-E20) of Curcuma longa L. exhibited significant inhibitory activity from $50{\mu}g/mL$. These results indicated that Curcuma longa L is a potent 5-alpha reductase II inhibitor for benign prostatic hyperplasia treatment.

본 연구에서는 울금(Curcuma longa L.)의 다양한 추출물을 대상으로 5-alpha reductase의 활성 저해 정도를 측정하였다. 5-Alpha reductase는 T에서 활성형 남성호르몬인 DHT로 전환을 담당하며, 전립선비대에서는 혈액에서 DHT 농도가 높다. Rat의 전립선조직 균질액과 5-alpha reductase를 과발현시킨 LNCaP 세포 균질액을 대상으로 측정한 결과, $100{\mu}g/mL$의 농도에서 울금의 열수추출물(CL-HW)과 20% 에탄올추출물(CL-E20)이 5-alpha reductase 활성을 효과적으로 저해하였다. 특히 CL-HW는 $100{\mu}g/mL$의 농도에서 80% 이상의 유의적 억제효과를 보였으며, CL-E20은 $50{\mu}g/mL$의 농도부터 80% 이상의 감소효과를 보였다. 이 같은 결과에서 CL-HW 및 CL-E20은 5-alpha reductase의 억제활성이 있으며, 이는 전립선비대 치료소재로 개발될 수 있는 가능성이 있음을 제안한다.

Keywords

References

  1. Pais P. 2010. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II. Adv Ther 27: 555-563. https://doi.org/10.1007/s12325-010-0041-6
  2. Kim YN, Kim MS, Chun SS, Choi JH. 2013. Effect of Phellius linteus water extract on benign prostatic hyperplasia. Nutr Res Pract 7: 172-177. https://doi.org/10.4162/nrp.2013.7.3.172
  3. Sun J, Xiang H, Yang LL, Chen JB. 2011. A review on steroidal $5\alpha$-reductase inhibitors for treatment of benign prostatic hyperplasia. Curr Med Chem 18: 3576-3589. https://doi.org/10.2174/092986711796642517
  4. Shin IS, Lee MY, Jung DY, Seo CS, Ha HK, Shin HK. 2012. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia. Food Chem Toxicol 50: 884-888. https://doi.org/10.1016/j.fct.2012.01.007
  5. Chaudhary UB, Turner JS. 2010. Finasteride. Expert Opin Drug Metab Toxicol 6: 873-881. https://doi.org/10.1517/17425255.2010.495944
  6. Wang X, Liao J, Yin D, Zhan F, Dai S, Xie G, Sang X. 2010. Establishment of a novel model for studying the effects of extracts of Chinese herb medicine on human type II 5alpha-reductase in vitro. Yakugaku Zasshi 130: 1207-1214. https://doi.org/10.1248/yakushi.130.1207
  7. Chandrasekaran CV, Sundarajan K, Edwin JR, Gururaja GM, Mundkinajeddu D, Agarwal A. 2013. Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction. Pharmacognosy Res 5: 71-79. https://doi.org/10.4103/0974-8490.110527
  8. Ramkissoon JS, Mahomoodally MF, Ahmed N, Subratty AH. 2012. Relationship between total phenolic content, anti oxidant potential, and antiglycation abilities of common culinary herbs and spices. J Med Food 15: 1116-1123. https://doi.org/10.1089/jmf.2012.0113
  9. Ho JN, Jang JY, Yoon HG, Kim Y, Kim S, Jun W, Lee J. 2012. Anti-obesity effect of a standardised ethanol extract from Curcuma longa L. fermented with Aspergillus oryzae in ob/ob mice and primary mouse adipocytes. J Sci Food Agric 2: 1833-1840.
  10. Stefanska B. 2012. Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus-insights into its mechanisms of action. Br J Pharmacol 166: 2209-2211. https://doi.org/10.1111/j.1476-5381.2012.01959.x
  11. Um MY, Hwang KH, Ahn J, Ha TY. 2013. Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase. Basic Clin Pharmacol Toxicol 113: 152-157. https://doi.org/10.1111/bcpt.12076
  12. Kang DI, Chung JI. 2013. Current status of $5\alpha$-reductase inhibitors in prostate disease management. Korean J Urol 54: 213-219. https://doi.org/10.4111/kju.2013.54.4.213
  13. Bisson JF, Hidalgo S, Rozan P, Messaoudi M. 2007. Therapeutic effect of ACTICOA powder, a cocoa polyphenolic extract, on experimentally induced prostate hyperplasia in Wistar-Unilever rats. J Med Food 10: 628-635. https://doi.org/10.1089/jmf.2006.242
  14. Ejike CE, Ezeanyika LU. 2010. Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds. Urol Int 87: 218-224.
  15. Gasco M, Villegas L, Yucra S, Rubio J, Gonzales GF. 2007. Dose-response effect of Red Maca (Lepidium meyenii) on benign prostatic hyperplasia induced by testosterone enanthate. Phytomedicine 4: 460-464.
  16. Hiipakka RA, Zhang HZ, Dai W, Dai Q, Liao S. 2002. Structure-activity relationships for inhibition of human 5alpha- reductases by polyphenols. Biochem Pharmacol 63: 1165-1176. https://doi.org/10.1016/S0006-2952(02)00848-1
  17. Jang S, Lee Y, Hwang SL, Lee MH, Park SJ, Lee IH, Kang S, Roh SS, Seo YJ, Park JK, Lee JH, Kim CD. 2007. Establishment of type II 5alpha-reductase over-expressing cell line as an inhibitor screening model. J Steroid Biochem Mol Biol 107: 245-252. https://doi.org/10.1016/j.jsbmb.2007.03.039

Cited by

  1. The Effects of Cortex Phellodendri on Prostatic Urethral Pressure and Mean Arterial Blood Pressure in an Experimental Rabbit Model vol.38, pp.2, 2017, https://doi.org/10.22246/jikm.2017.38.2.110
  2. Anti-acne vulgaris effect including skin barrier improvement and 5α-reductase inhibition by tellimagrandin I from Carpinus tschonoskii vol.19, pp.1, 2014, https://doi.org/10.1186/s12906-019-2734-y